Epigral (NSE:EPIGRAL) Net Change in Cash : ₹0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Epigral Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Epigral's Net Change in Cash for the three months ended in Mar. 2024 was ₹0 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0 Mil.

Epigral Net Change in Cash Historical Data

The historical data trend for Epigral's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epigral Net Change in Cash Chart

Epigral Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Net Change in Cash

Get a 7-Day Free Trial

-1,291.17

5.83

244.05

-108.45

-110.57

Epigral Quarterly Data
	Mar18	Mar19	Mar20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Change in Cash	Get a 7-Day Free Trial											-	-	-	-	-

Epigral Net Change in Cash Calculation

Epigral's Net Change in Cash for the fiscal year that ended in Mar. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	3976.401	+	-4010.989	+	-75.982	+	0
	=	-111

Epigral's Net Change in Cash for the quarter that ended in Mar. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 0 + 0 + 0 + 0

= 0

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Epigral Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Epigral's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Epigral (NSE:EPIGRAL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Epigral Ltd (NSE:EPIGRAL) » Definitions » Net Change in Cash

Comparable Companies

BOM:506222 BOM:500339 BOM:530001 BOM:500052 BOM:500150 BOM:500201 BOM:500171 BOM:500117 BOM:506618 BOM:500199 SAU:2010 TSE:4063 XTER:BAS DOW XKRX:051910 SZSE:002493 SHSE:600989 CE XKLS:5183 XKRX:086520

Traded in Other Exchanges

543332:India

Address

Corporate Road, 5th Floor, 6th Floor & 7th Floor, Meghmani House, Behind Safal Profitaire, Prahladnagar, Ahmedabad, GJ, IND, 380015

Website

https://www.meghmanifinechem.com

Epigral Ltd Formerly Meghmani Finechem Ltd is a producer of Chlor-Alkali and its Derivatives and specialty chemicals with backward and forward integration facilities. It manufactures Caustic Soda, Caustic Potash, CPVC Resin, Epichlorohydrin, Chlorine, Hydrogen, Chloromethanes, and Hydrogen Peroxide. The company is focused on servicing domestic as well as international markets.

Epigral (NSE:EPIGRAL) Headlines

No Headlines